Skip to main content

Iovate Health Sciences USA Inc. Recall: Presence of cathine in product

United States

TerminatedClass II

Company
Iovate Health Sciences USA Inc.
Product
Alpha Test 120 count Black labeled plastic bottle, 12 bottle…
Recall date
December 18, 2024
Terminated
November 3, 2025
Source
FDA

Reason for recall

Presence of cathine in product

  1. - Recall initiated
  2. - Reported by source
  3. - Recall terminated
Recalled products
Product description UPC Quantity Lot / code information
Alpha Test 120 count Black labeled plastic bottle, 12 bottles per case of 120 count capsules each per bottle, Store in a cool, dry place (60 F to 80 F), UPC 6-31656-60676-8, SKU0001191, SKU0002075 6-31656-60676-8 Total 163,248 units Expiration Date and Lot Codes: March 21, 2027 (Lots 24A125, 24B059, 24B060) March 22, 2027 (Lot 24C112) July 3, 2027 (Lots 24F164, 24G112) July 4, 2027 (Lot 24E288) July 5, 2027 (Lots 24G243, 24H207)

Distribution

  • Domestic and foreign distribution:NC
  • CA
  • TX
  • NJ
  • VA
  • NV
  • PA
  • IN
  • NY
  • CA
  • IL
  • MS
  • KY
  • MI
  • SC
  • WA
  • CT
  • FL
  • OH
  • WI
  • DE
  • LA
  • TN
  • MO
  • UT
  • KH
  • GA
  • KS
  • CO
  • IA
  • AZ
  • OR. Foreign distribution: ZA
  • PH
  • IS
  • KZ
  • AE

Official source record

Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
F-0455-2025
Event ID
96054
Status
Terminated
Classification
Class II
Company
Iovate Health Sciences USA Inc.
Product description
Alpha Test 120 count Black labeled plastic bottle, 12 bottles per case of 120 count capsules each per bottle, Store in a cool, dry place (60 F to 80 F), UPC 6-31656-60676-8, SKU0001191, SKU0002075
Quantity
Total 163,248 units
Reason
Presence of cathine in product
Recall initiation date
December 18, 2024
Report date
February 5, 2025
Classification date
Not published in this source record
Termination date
November 3, 2025
Distribution pattern
Domestic and foreign distribution:NC, CA, TX, NJ, VA, NV, PA, IN, NY, CA, IL,MS, KY, MI,SC, WA, CT, FL, OH, WI, DE, LA, TN, MO, UT, KH, GA, KS, CO, IA, AZ, OR. Foreign distribution: ZA, PH, IS, KZ, AE
UPC, lot, and code information
UPC 6-31656-60676-8; Expiration Date and Lot Codes: March 21, 2027 (Lots 24A125, 24B059, 24B060) March 22, 2027 (Lot 24C112) July 3, 2027 (Lots 24F164, 24G112) July 4, 2027 (Lot 24E288) July 5, 2027 (Lots 24G243, 24H207)
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Letter
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date

Responsible company: Iovate Health Sciences USA Inc.

Distribution map

A map highlighting the states named in the source's distribution description.

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map
State Distributed
North Carolina 1
California 1
Texas 1
New Jersey 1
Virginia 1
Nevada 1
Pennsylvania 1
Indiana 1
New York 1
Illinois 1
Mississippi 1
Kentucky 1
Michigan 1
South Carolina 1
Washington 1
Connecticut 1
Florida 1
Ohio 1
Wisconsin 1
Delaware 1
Louisiana 1
Tennessee 1
Missouri 1
Utah 1
Georgia 1
Kansas 1
Colorado 1
Iowa 1
Arizona 1
Oregon 1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.